Self-emulsifying and selfmicroemulsifying formulations for the oral administration of taxoids

Details for Australian Patent Application No. 2004262495 (hide)

Owner Aventis Pharma S.A.

Inventors Cote, Sophie; Peracchia, Maria-Teresa; Gaudel, Gilbert

Agent Watermark

Pub. Number AU-B-2004262495

PCT Pub. Number WO2005/014048

Priority 03291798.1 18.07.03 EP

Filing date 15 July 2004

Wipo publication date 17 February 2005

Acceptance publication date 3 February 2011

International Classifications

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

Event Publications

9 February 2006 PCT application entered the National Phase

  PCT publication WO2005/014048 Priority application(s): WO2005/014048

3 February 2011 Application Accepted

  Published as AU-B-2004262495

2 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004262496-Semi-solid formulations for the oral administration of taxoids

2004262494-Means and methods for treating a disease which is associated with an excess transport of hyaluronan across a lipid bilayer